Ze-chao Zhang
Nanning, 530000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Qianlong Shutong Formula alleviates benign prostatic hyperplasia associated with the regulation of inflammation, fibrosis and the Hippo-YAP/TAZ pathway.
Journal: Tissue & cell
Published: February 12, 2026
Mechanism of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia by Regulating Metabolism and Protein Function.
Journal: Biomedical chromatography : BMC
Published: January 09, 2026
Review of Chinese medicine intervention in PI3K/AKT pathway to regulate fibrosis.
Journal: Medicine
Published: July 15, 2025
Association of endometriosis with hematuria markers: A Mendelian randomization study.
Journal: Medicine
Published: June 24, 2025
The association between benign and malignant prostatic hyperplastic diseases and blood and urine biomarkers: A Mendelian randomization study.
Journal: Medicine
Published: March 11, 2025
Verification of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia.
Journal: Combinatorial chemistry & high throughput screening
Published: July 18, 2024
Research progress in the relationship of hypoxia-inducible factor 1 with prostate diseases in hypoxic environment
Journal: Zhonghua nan ke xue = National journal of andrology
Published: April 10, 2024
Bidirectional causal relationship between inflammatory cytokines and endometriosis at different sites.
Journal: BMC women's health
Published: February 09, 2024
The relationship between circulating metabolites and prostate hyperplasia: a Mendelian randomization study.
Journal: Aging clinical and experimental research
Published: August 28, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026